Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Inositols: From Established Knowledge to Novel Approaches

30 Sept 2021

Abstract excerpt

Myo-inositol (myo-Ins) and D-chiro-inositol (D-chiro-Ins) are natural compounds involved in many biological pathways. Since the discovery of their involvement in endocrine signal transduction, myo-Ins and D-chiro-Ins supplementation has contributed to clinical approaches in ameliorating many gynecological and endocrinological diseases. Currently both myo-Ins and D-chiro-Ins are well-tolerated, effective...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Growth Hormone and Insulin-like Growth Factors
Share to Ovarian function and disorders
Share to Reproductive Biology and Fertility

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34638926
DOI: 10.3390/ijms221910575

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Inositols: From Established Knowledge to Novel ApproachesPMID 34638926Read ↗

Myo-Inositol and Its Derivatives: Their Roles in the Challenges of InfertilitySemantic proximity Read ↗

Use of Inositols in Polycystic Ovary SyndromeSemantic proximity Read ↗

Results from the International Consensus Conference on myo-inositol and D-chiro-inositol in Obstetrics and Gynecology – assisted reproduction technologySemantic proximity Read ↗

The Effects of Myo-Inositol and D-Chiro-Inositol in a Ratio 40:1 on Hormonal and Metabolic Profile in Women with Polycystic Ovary Syndrome Classified as Phenotype A by the Rotterdam Criteria and EMS-Type 1 by the EGOI Criteria.Semantic proximity Read ↗

Melatonin and Myo-Inositol: Supporting Reproduction from the Oocyte to BirthSemantic proximity Read ↗

Myo‐inositol in health and disease: its impact on semen parameters and male fertilitySemantic proximity Read ↗

Comparative efficacy of combined myo-inositol and D-chiro inositol versus metformin across PCOS Phenotypes: enhancing ovarian function, ovulation, and stress response in a prospective clinical trial.Semantic proximity Read ↗

Is it time to consider patients suffering from endometriosis-related infertility as “novel candidates” for targeted peri-conceptional D-chiro inositol supplementation? Hypothesis, rationale and some considerationsSemantic proximity Read ↗

The effect of Myo-Inositol supplement on molecular regulation of folliculogenesis, steroidogenesis, and assisted reproductive technique outcomes in patients with polycystic ovarian syndromeSemantic proximity Read ↗

Irisin, Energy Homeostasis and Male ReproductionSemantic proximity Read ↗

Tailoring treatment for PCOS phenotypes.Semantic proximity Read ↗

Does myo-inositol effect on PCOS follicles involve cytoskeleton regulation?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.